OTC · Drug Manufacturers - Specialty & Generic

NutraLife BioSciences, Inc. (NLBS) Stock

$0.00 OTC: NLBS Healthcare

NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products.

Valuation

MetricValue
Price$0.00
Market Cap$17662
P/E Ratio0.00
P/B Ratio-0.02
P/S Ratio0.02
EPS (TTM)$-0.04
52-Week High—
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE600.00%
ROA-120.00%
ROCE—
Gross Margin-400.00%
Operating Margin-400.00%
Net Margin-600.00%
Debt/Equity-3.00
Current Ratio0.20

Annual Financials (USD)

Metric20172018201920202021
Revenue$2.0M$4.0M$2.0M$1.0M$1.0M
Operating Profit$-20.0M$-2.0M$-3.0M$-2.0M$-4.0M
Net Profit$-24.0M$-2.0M$-4.0M$-3.0M$-6.0M
EPS$-0.33$-0.02$-0.04$-0.02$-0.04
Op Margin-1133.4%-51.4%-159.1%-157.1%-713.8%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$1.0M$2.0M$4.0M$5.0M$5.0M
Total Liabilities$0$1.0M$3.0M$4.0M$6.0M
Cash$0$0$0$0$0
Borrowings$0$0$2.0M$3.0M$3.0M

Latest News

Net Asset Value(s) Business Wire · Aug 11, 2026 Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront Pharmaceutical Technology · Aug 11, 2026 Jefferies Adjusts Price Target on Expedia to $375 From $310, Maintains Buy Rating MT Newswires · Aug 11, 2026 Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating MT Newswires · Aug 11, 2026 JPMorgan Adjusts Price Target on MetLife to $108 From $106, Maintains Overweight Rating MT Newswires · Aug 11, 2026

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-1.0M$0$-3.0M$-1.0M$0
Investing Cash Flow$0$-1.0M$-3.0M$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$-1.0M$-5.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.83
FCF Yield-2759.52%
Quick Ratio0.04
Interest Coverage-2.42
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACCAAcacia Diversified Holdings, Inc. $0.00 — 0.00 $5428 0.00%
ACORQAcorda Therapeutics, Inc. $0.01 -24.81% 0.00 $12421 0.00%
CBDHFHempfusion Wellness Inc. $0.00 — 0.00 $1635 0.00%
CHCRAdvanzeon Solutions, Inc. $0.00 — — $11991 0.00%
DGCRFDiagnocure, Inc. $0.00 — 0.00 $21520 0.00%

About NutraLife BioSciences, Inc.

NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.

NutraLife BioSciences, Inc. (NLBS) stock trades at $0.00 with a market capitalization of $17662. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.02, price-to-sales of 0.02.

On profitability, NutraLife BioSciences, Inc. generates a return on equity (ROE) of 600.00% — well above the market average, a sign of a high-quality business, an operating margin of -400.00%, a net profit margin of -600.00%.

Official website: drinknutralife.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides